ATNM

Actinium Pharmaceuticals (ATNM)

About Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, discovery, and clinical development of targeted radiotherapies. It also develops and markets medicines for relapsed and refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.

Details

Daily high

$1.31

Daily low

$1.22

Price at open

$1.23

52 Week High

$1.95

52 Week Low

$0.95

Market cap

41.1M

Dividend yield

0.00%

Volume

1,548

Avg. volume

286,357

P/E ratio

-1.21

Actinium Pharmaceuticals News